ANNEX IISupplementary provisions
ANNEX II In Part C of the Annex to Implementing Regulation (EC) No 540/2011, the following entry is added: Number Common Name, Identification Numbers IUPAC Name Purity ( *1 ) Date of approval Specific provisions ‘7 Salix spp. cortex CAS No: not allocated CIPAC No: not allocated Not applicable European Pharmacopeia 1 July 2015 Salix cortex shall be used in accordance with the specific conditions included in the conclusions of the review report on Salix spp. cortex (SANCO/12173/2014) and in particular Appendices I and II thereof.’ ( *1 ) Further details on identity, specification and manner of use of basic substance are provided in the review report.